Decoding the evidence: A synopsis of indications and evidence for catheter ablation in atrial fibrillation (Review).

Medicine international Pub Date : 2024-11-05 eCollection Date: 2025-01-01 DOI:10.3892/mi.2024.200
Omar Obeidat, Mohamed F Ismail, Saeed Abughazaleh, Hashim Al-Ani, Mohammad Tarawneh, Laith Alhuneafat, Ali Obeidat, Abedallah Obeidat, Qusai Alqudah, Moh'd Alamin Daise, Hamza Alzghoul, Mohammad Al-Hammouri, Ward Althunibat, Ann Tong, Mazahir Alimohamed
{"title":"Decoding the evidence: A synopsis of indications and evidence for catheter ablation in atrial fibrillation (Review).","authors":"Omar Obeidat, Mohamed F Ismail, Saeed Abughazaleh, Hashim Al-Ani, Mohammad Tarawneh, Laith Alhuneafat, Ali Obeidat, Abedallah Obeidat, Qusai Alqudah, Moh'd Alamin Daise, Hamza Alzghoul, Mohammad Al-Hammouri, Ward Althunibat, Ann Tong, Mazahir Alimohamed","doi":"10.3892/mi.2024.200","DOIUrl":null,"url":null,"abstract":"<p><p>The present study reviews the role of catheter ablation (CA) in the management of atrial fibrillation (AF), a widespread arrhythmia associated with increased morbidity and mortality. The present review explores current indications and recent evidence supporting CA, assessing patient outcomes and identifying common complications associated with the procedure. Emphasis is placed on optimizing risk factors prior to ablation, including weight control and hypertension management, as these measures can significantly enhance post-procedural outcomes. The present review also discusses the use of antiarrhythmic and anticoagulant therapies following CA to minimize recurrence and reduce stroke risk. Additionally, the cost-effectiveness of CA is discussed, comparing its long-term economic impact with that of medical therapy alone. The present comprehensive review provides insight into best practices for AF management, supporting CA as a promising approach when integrated with targeted lifestyle modifications and pharmacological support for improved, patient-centered outcomes.</p>","PeriodicalId":74161,"journal":{"name":"Medicine international","volume":"5 1","pages":"1"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571048/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/mi.2024.200","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The present study reviews the role of catheter ablation (CA) in the management of atrial fibrillation (AF), a widespread arrhythmia associated with increased morbidity and mortality. The present review explores current indications and recent evidence supporting CA, assessing patient outcomes and identifying common complications associated with the procedure. Emphasis is placed on optimizing risk factors prior to ablation, including weight control and hypertension management, as these measures can significantly enhance post-procedural outcomes. The present review also discusses the use of antiarrhythmic and anticoagulant therapies following CA to minimize recurrence and reduce stroke risk. Additionally, the cost-effectiveness of CA is discussed, comparing its long-term economic impact with that of medical therapy alone. The present comprehensive review provides insight into best practices for AF management, supporting CA as a promising approach when integrated with targeted lifestyle modifications and pharmacological support for improved, patient-centered outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
证据解码:心房颤动导管消融术的适应症和证据概要(综述)。
心房颤动是一种广泛存在的心律失常,与发病率和死亡率的增加有关,本研究回顾了导管消融术(CA)在心房颤动治疗中的作用。本综述探讨了当前的适应症和支持 CA 的最新证据,评估了患者的治疗效果,并确定了与手术相关的常见并发症。重点在于消融术前优化风险因素,包括控制体重和高血压,因为这些措施可显著提高术后疗效。本综述还讨论了 CA 术后抗心律失常和抗凝疗法的使用,以尽量减少复发和降低中风风险。此外,本综述还讨论了 CA 的成本效益,比较了 CA 与单纯药物治疗的长期经济影响。本综述深入探讨了房颤管理的最佳实践,支持将 CA 与有针对性的生活方式调整和药物支持相结合,以改善以患者为中心的疗效,将 CA 作为一种很有前景的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Acute presentation of short‑segment Hirschsprung's disease treated with Soave's procedure in a 20‑year‑old male: A case report and mini‑review of the literature. Screening for proline‑rich protein 11 gene expression in cervical cancer: Use as a novel diagnostic biomarker and poor prognostic factor. Examining the growing challenge: Prevalence of diabetes in young adults (Review). Decoding the evidence: A synopsis of indications and evidence for catheter ablation in atrial fibrillation (Review). Determination of a 'point of no return' in refractory chronic subdural hematomas: A case report and review of the literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1